Exchange: NASDAQ·Updated 07:23 PM EDT
ABUS logo

ABUS Arbutus Biopharma Corp

$5.17
$0.03
(0.59%)
Today
Closed $5.15
$0.0153
(0.30%)
After Hours
Reported EarningsAug 12
Mkt Cap$1.01B
Vol5.2M

About ABUS

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.
51

Neutral Sentiment

How do you feel about ABUS?

Advertisement|Remove ads.